Stemtech Corporation Announces Strategic Leadership Additions and Milestones Toward StemPets(TM) Launch in 2025
NAPLES, FL / ACCESS Newswire / March 10, 2025 / Stemtech, the global leader in stem cell nutrition, is proud to announce key strategic appointments and a forward-looking path toward the launch of its highly anticipated StemPets product line. With an unwavering commitment to enhancing the lives of individuals and their pets, Stemtech continues to innovate in the stem cell and wellness space.
Launch of StemPets™: A Game Changer in Pet Health
Stemtech is on track to launch StemPets in early Q2 of 2025, marking a significant expansion into the burgeoning pet healthcare sector. With projections indicating the global pet care market is expected to reach over $303 billion by 2027, Stemtech's entry into this market is poised to capture substantial growth, leveraging its leadership in stem cell nutrition.
'We are excited to bring the power of stem cell nutrition to pets, offering a breakthrough solution for pet owners who want to improve their animals' health and wellness,' said John W. Meyer, President & COO of Stemtech. 'StemPets is a game changer in pet care, and with the exponential growth in the sector, we believe we are uniquely positioned to capture a significant share of this rapidly expanding market. This is an exciting time for investors, as we are poised to capitalize on a booming industry with innovative, science-backed products that will transform pet healthcare.'
New Leadership Appointments to Drive Global Growth
As part of Stemtech's continued expansion, we are pleased to welcome two highly accomplished professionals to our executive team. These strategic appointments underscore Stemtech's commitment to global growth, innovation, and leadership in stem cell nutrition.
Alejandro Carrillo has been positioned in his new role of Vice President of Global Operations. 'Alex' has been with Stemtech for the past ten years in global sales and marketing. Building on this experience, Alex will now head up all global operations activities, focusing on manufacturing, inventory and expansion management.
Srilakshmi Vadlapatla has been appointed as Global Accounts Manager and will assume the role of Chief Financial Officer (CFO), responsible for all Stemtech finance matters, in the near future. With her extensive experience in global finance and business strategy, Srilakshmi will play a critical role in shaping Stemtech's financial future as the company continues to scale globally. She brings a wealth of experience in multi-national finance, having worked with top-tier companies where she led teams responsible for overseeing international financial operations, strategic planning, and capital management. Srilakshmi's deep understanding of global markets and her proven track record of successfully driving financial growth will be invaluable as Stemtech moves into the next phase of its development.
Manuel Ramirez Garcia joins Stemtech as Director of Global Sales & Field Development. Manuel brings a wealth of expertise in global sales strategy and field operations, positioning Stemtech for strong growth and increased market share across its expanding international markets. With over 20 years of experience in international sales, Manuel has developed and executed strategies that led to significant revenue growth across multiple regions, including North America, Europe, and Asia. His extensive background in leading diverse sales teams and building robust distributor networks will be key to driving Stemtech's global expansion and market penetration.
'We are excited to have Srilakshmi and Manuel join our leadership team along with Alex in his new role,' said John W. Meyer, President and COO. 'Their combined expertise in finance, global sales, and field operations will be pivotal as we continue to expand Stemtech's footprint worldwide. With their leadership, we are poised for even greater growth and innovation in the stem cell nutrition industry.'
We also want to take a moment to express our deep gratitude to James S. 'Jay' Cardwell for his outstanding service and contributions to Stemtech while our CFO. Jay's leadership has been invaluable in helping Stemtech reach new heights, and we wish him all the best in his future endeavors.
These strategic appointments and the highly anticipated launch of StemPets underscore Stemtech's ongoing commitment to innovation, enhancing shareholder value, and maintaining industry leadership. Stemtech's proven expertise and pioneering role in stem cell nutrition positions the company ideally to capitalize on the rapid growth in both human and pet healthcare markets.
'We are entering an exciting new chapter of growth and innovation at Stemtech,' said Charles S. Arnold, Chairman and CEO. 'With the upcoming launch of StemPets and our strengthened executive team, we are strategically positioned to lead the booming pet healthcare market. We invite investors, wellness seekers, and stakeholders to join us in shaping a healthier future and driving sustained success through 2025 and beyond.It gives me great pleasure to share that every week we receive heartfelt messages from men and women expressing gratitude for the meaningful improvement Stemtech products have brought to their quality of life. With the upcoming launch of StemPets, we look forward to extending these transformative benefits to pets, helping families everywhere enjoy healthier, happier lives alongside their beloved animals.'
ABOUT STEMTECH
Stemtech Corporation, a leading stemceutical™ company with a direct sales distribution model, was founded on April 18, 2018, after acquiring the operations from its predecessor Stemtech International, Inc., which was established in 2005. From 2010 through 2015, Stemtech International, Inc., was recognized four separate times on the Inc. 5000 Fastest-Growing Companies list. In 2018, Stemtech underwent an extensive executive reorganization, and continued operations under new leadership as Stemtech Corporation. In August 2021, Stemtech became a publicly traded company (STEK) and has expanded business opportunities for its Independent Business Partners (IBPs), who may earn incomes by sharing Stemtech products. Stemtech is well positioned as the pioneer in stem cell nutrition, oral, skin care and soon pet health products, to increase sales in the wellness industry.
Stemtech's comprehensive product portfolio reflects its dedication to optimal health. Our all-natural innovations like stemrelease3™ (release of the adult stem cells from the bone marrow), StemFlo™ Advanced (circulation of the stem cells through the bloodstream), MigraStem® (migration from the blood stream into the area need support), and OraStem® Toothpaste (whitening teeth, freshening breath, anti-microbial, promoting good gum health) demonstrate the company's unwavering commitment to quality-of-life products and natural effectiveness. The recent launch of Cellect One® Shield: HOCL-a multipurpose mist for skin care, cleaning, and disinfecting-and its integration with the Cellect One® Rapid Renew Stem Cell Peptide Night Cream (featuring the patented QXP ingredient) underscore Stemtech's innovative edge in the beauty, health and wellness industry.
Looking ahead, Stemtech is set to break new ground with the April 2025 debut of StemPets™ - a nutritional supplement designed for both dogs and cats. Tapping into the booming global pet wellness market, currently valued at over $303 billion annually, Stemtech is poised to transform pet health, with early adopters reporting remarkable improvements in health, energy, mood, and skin and hair quality for their furry family members.
For nearly 20 years, Stemtech has not only championed the benefits of natural, plant-based ingredients but has also led the way in scientific innovation within the wellness, anti-aging, and longevity sectors. As industry forecasts and studies from reputable sources like the Global Wellness Institute project unprecedented growth, Stemtech's unwavering commitment to quality and innovation ensures that they will remain at the forefront of this transformative journey-making everyone healthier, while slowing down the aging process naturally.
FORWARD LOOKING STATEMENTS
This announcement contains forward-looking statements within the meaning of the 'safe harbor' provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, those identified by words such as 'believes,' 'will,' 'expects,' 'anticipates,' 'estimates,' 'intends,' 'plans,' 'targets,' 'projects' and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in these forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, the results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, the impact of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices, and other risks discussed from time to time in our filings with the Securities and Exchange Commission, including our latest 10-Q Report filed on November 19, 2024. We undertake no obligation to update any forward-looking statements, or any information contained in this press release or in other public disclosures, at any time. Finally, the investing public is reminded that only announcements or information about Stemtech Corporation disseminated by the Company and bearing its name are considered official.
Stemtech Corporation
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
3 hours ago
- Time Business News
YourSecret: The Upcoming Anonymous Social Platform That May Redefine Digital Privacy and Online Expression
By Time Business News Contributor In a digital economy dominated by surveillance capitalism and identity-driven engagement, a new platform is preparing to challenge the status quo. Slated for release in fall 2025, YourSecret positions itself as a privacy-first, anonymous social space aimed at reshaping the way we share, speak, and connect online. Recently unveiled through AccessNewswire, the YourSecret platform is already attracting attention from tech analysts, investors, and privacy advocates alike — for its bold promise: no names, no likes, no algorithms, and no tracking. 'No real identities. No pressure to perform. Just raw expression,' the founding team writes. 'We believe people communicate most authentically when no one is watching.' At its core, YourSecret revives the ethos of early internet culture — message boards, confessional blogs, and pseudonymous creativity — but does so with a refined, mobile-first UX and a forward-looking tech stack. No personal logins or phone verification Anonymous publishing and interaction A chronological feed without algorithmic curation End-to-end moderation and AI-based behavioral filters (details to be revealed pre-launch) Minimalist web and mobile app experience YourSecret is expected to allow users to post thoughts, stories, observations, or questions without revealing anything about their identity. There will be no follower counts, vanity metrics, or reputation systems — creating a horizontal space where content matters more than profile aesthetics. In the wake of growing global debates about digital rights, platform ethics, and data exploitation, user demand is shifting. A significant segment of Gen Z and Millennials — two of the most overexposed generations online — are showing increased interest in 'digital quiet zones': spaces that prioritize safety, authenticity, and privacy over virality and monetization. YourSecret is not the only player in the anonymous space. However, its zero-data policy, combined with planned AI-enhanced community tools, may give it an edge over older anonymous platforms that often struggled with content quality or safety. Unlike the majority of social networks that rely on ad revenue and user profiling, Your Secret hints at alternative monetization models. The platform has not disclosed its full strategy, but early indicators suggest possibilities such as: Freemium subscriptions Tipping systems for content creators Community-supported funding (crowdfunding or tokenized models) This approach aligns with broader ethical tech movements that reject the commodification of user behavior in favor of long-term trust and transparency. For investors, marketers, and digital entrepreneurs, YourSecret may represent more than just another app — it could signal the next evolutionary phase of online interaction: from performance to presence, from exposure to intimacy, from branding to being. If it succeeds in building a sustainable, moderated, and user-centric community, Your Secret may emerge as a blueprint for what the next generation of social networks will look like — decentralized in spirit, human in tone, and radically private by design. The official launch is expected in Q4 2025, with both mobile and web versions planned for simultaneous release. While funding and partnership details remain undisclosed, early buzz suggests that YourSecret has ambitions beyond just niche appeal. We will continue monitoring the rollout of YourSecret and how it resonates with a digital public increasingly hungry for safer, quieter, and more honest online environments. accessnewswire/Secret/Your Secret/ TIME BUSINESS NEWS
Indianapolis Star
16 hours ago
- Indianapolis Star
New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP)
This week's episode is sponsored by The Sustainable Green Team's Waterless Garden (OTC:SGTM) and PetVivo Holdings, Inc.'s (NASDAQ:PETV) innovative SPRYNG™ product. NEW YORK CITY, NY / ACCESS Newswire / June 14, 2025 / New to The Street, the nationally syndicated business television series known for spotlighting innovation across sectors, announces the premiere of Episode #671 airing tonight on Bloomberg Television at 6:30 PM EST. This week's broadcast features five dynamic companies making waves across blockchain, AI, health tech, wellness, and pharmaceutical sectors: FLOKI – The globally recognized crypto and blockchain brand building Web3 utility through its DeFi ecosystem. Arrive AI (NASDAQ:ARAI) – Developer of a patented smart mailbox delivery platform, leading last-mile logistics innovation with its autonomous, AI-powered systems. Health In Tech (NASDAQ:HIT) – A pioneer in digital underwriting and quote-to-card technology for health insurance, transforming how plans are built and priced. Vita Bella – A wellness brand that continues to expand its national presence through health-focused lifestyle offerings. NRX Pharmaceuticals (NASDAQ:NRXP) – A late-stage pharmaceutical company advancing treatments for CNS disorders and respiratory distress. This week's featured corporate sponsors include: The Sustainable Green Team (OTC:SGTM) and its revolutionary Waterless Garden initiative for drought-resistant, sustainable landscaping. PetVivo Holdings, Inc. (NASDAQ:PETV), showcasing continued progress with its SPRYNG™, a veterinary injectable device for treating osteoarthritis in companion animals. Upcoming Highlights: New to The Street has also wrapped filming this week with several prominent brands: GLINT Pay (Private) – A disruptive gold-as-money platform allowing real-time gold transactions. Lahontan Gold Corp. (TSX.V:LG / OTCQB:LGCXF) – Canadian gold exploration company with high-grade assets in Nevada. Greer Consulting Group – Providing strategic solutions across regulatory compliance, M&A, and executive strategy. Special Feature Segment: A culinary showcase from two of New York City's most iconic dining destinations – Black Barn and Hunt & Fish Club – blending luxury hospitality with the business of restaurant branding. Additionally, special segments fromIMG Academy, Skip Barber Racing School, and KITON will continue to roll out in the coming months as part of New to The Street's ongoing coverage of elite performance, luxury, and innovation. Quote from Vince Caruso, Creator and Executive Producer of New to The Street: 'We continue to be a destination for innovative and publicly traded companies ready to tell their story at scale. Tonight's show blends AI, healthcare, crypto, and wellness with real national TV exposure. We're proud to feature these brands and grateful to our show sponsors for helping amplify their messages.' About New to The Street Since 2009, New to The Street has become one of the most trusted platforms for public and private companies to share their stories. The show combines sponsored programming with earned media, enhanced by iconic outdoor campaigns, nationwide TV commercials, and non-deal roadshows that connect executives with top-tier investors and institutions. With weekly reach across 220 million linear TV households, a growing 2.65 million YouTube subscribers, and a robust social media presence exceeding 700,000 followers across LinkedIn, Facebook, Instagram, and X, New to The Street delivers unparalleled exposure and credibility in the business media space. For more information, visit SOURCE: New To The Street View the original press release on ACCESS Newswire
Business Wire
a day ago
- Business Wire
Securonix Acquires ThreatQuotient to Deliver Industry's Broadest and Deepest Threat Detection Investigation and Response
PLANO, Texas--(BUSINESS WIRE)--Today, Securonix, a five-time Leader in the Gartner® Magic Quadrant™ for Security Information and Event Management (SIEM), announced the acquisition of ThreatQuotient, a four-time leader in threat intelligence based on QKS Group Spark Matrix report and the force behind ThreatQ, the most innovative external threat intelligence platform. This combination will create a comprehensive, modular, and fully integrated AI-driven platform for threat detection, investigation, and response (TDIR), leveraging advanced analytics and insights across both internal and external threats. This acquisition accelerates the modernization of security operations by uniting internal and external threat intelligence with real-time analytics and agentic AI. Unlike external threat intelligence bolt-on solutions with disconnected management interfaces, the integrated platform from Securonix and ThreatQuotient will deliver unified visibility, faster response, and greater operational clarity. "Bringing threat intelligence management and SIEM together in a unified platform is a game changer. We've already seen the value of deeply enriched advanced analytics and detection in our Securonix SIEM environment—but coupling that with integrated threat curation, prioritization, and response should help customers move even faster. It means fewer swivel-chair investigations, more accurate triage, and greater confidence that security analysts are working with the most relevant threats. This kind of integration has the potential to accelerate the ability to detect, respond, and stay ahead," said Marcel Jonker, Director of Cybersecurity Operations at Cambia Health Systems. The integration of Securonix and ThreatQuotient promises to deliver up to a 70% reduction in Mean Time to Respond (MTTR), enabling security teams to detect, investigate, and remediate threats significantly faster. By combining curated threat intelligence with AI-driven automation, the solution will deliver exponential improvements in filtering out false positives, enriching alerts with actionable context, and automating historical threat sweeps and incident response. This reduces alert overload, speeds up root cause analysis, and minimizes manual handoffs—cutting investigation time from hours to minutes and enabling automated containment before threats escalate. 'Security teams are drowning in noise and struggling to keep up with evolving threats,' said Kash Shaikh, CEO and President of Securonix. 'This acquisition brings together Securonix's Agentic AI-driven Platform with ThreatQuotient's deep threat intelligence to deliver clarity, speed, and automated workflows to our customers, reducing false positives by up to 90%. Together, we're building the modern SOC Platform—proactive, intelligent, and built for what's next.' Kash added, 'Securonix and ThreatQuotient bring together complementary strengths—deep innovation across internal and external threat domains, and a shared commitment to innovation and customer service. Both companies serve enterprise and government customers as well as managed security service providers (MSSPs), and we're excited to welcome the talented ThreatQuotient team and their customers to Securonix.' Purpose-Built for Analysts. Proven Against Real-World Threats. ThreatQuotient's Threat Intelligence Platform (TIP) strength lies in delivering curated, contextualized threat intelligence that drives smart, timely decisions. When combined with Securonix's EON Agentic AI-based SIEM, SOAR, UEBA and Data Pipeline Manager, customers can accelerate their migration from reactive threat hunting-based defense to proactive, real-time, behavior-driven, open-agentic security operations. With this integration, Securonix customers and partners will enjoy the following benefits: Gain clear visibility: Integrate deep enriched real-time analytics from Securonix with curated external intelligence from ThreatQuotient to create a single, high-context stream of alerts. Eliminate blind spots and accelerate threat identification with confidence. Stay ahead of risk: Auto-enrich Indicator of compromise (IoCs) and preemptively respond to repeat attacks, blocking 90 percent before they start. Act smarter: Automate repetitive tasks, reduce false positives, and streamline investigations. Teams can stay focused on high-priority threats and reduce time spent on manual triage. Deploy your way: Continue to use ThreatQ as a standalone threat intelligence platform or as part of the fully integrated Securonix solution. Deploy on-premise or SaaS in a way that fits the current architecture and scales with needs. Accelerated Roadmap: Combined R&D synergies will accelerate upcoming roadmap innovations, including Agentic AI and ThreatQuotient's innovation priorities. With this acquisition, ThreatQuotient customers and partners will enjoy the following benefits: Increased Scale: ThreatQ customers can take advantage of Securonix's global R&D scale and GTM reach, including access to Securonix's Threat Labs Intelligence. Deeper Integrations: Gain access to an enriched roadmap and integration between Securonix's best-in-class SIEM, SOAR, and UEBA portfolio and ThreatQ, including extension of Agentic AI advancements. Continued Focus: Zero interruption of their existing service, as ThreatQuotient will continue to operate as a standalone offering, with no disruption to existing roadmap and workflows. 'Enterprises, government institutions and managed security service providers rely on ThreatQuotient to protect their mission critical businesses. Joining Securonix marks a powerful new chapter for ThreatQuotient. By uniting our strengths, we can accelerate innovation, expand our reach, and deliver greater value to our customers. I'm proud of what we've built and excited for what's ahead,' said John Czupak, CEO of ThreatQuotient. BTIG, LLC served as exclusive financial advisor, and King & Spalding LLP served as legal advisor to ThreatQuotient. Vinson & Elkins LLP served as legal advisor to Securonix. About Securonix Securonix is leading the transformation of cybersecurity with the industry's first Unified Defense SIEM powered by agentic AI, purpose-built to decide and act across the threat lifecycle with a human-in-the-loop philosophy. Built for scale, precision, and speed, our cloud-native platform empowers global enterprises to shift from reactive security to proactive, autonomous operations. Recognized as a Leader in the Gartner® Magic Quadrant™ for SIEM and a Customers' Choice by Gartner Peer Insights™, Securonix is driving the next era of intelligent, autonomous security operations. Learn more at About ThreatQuotient ThreatQuotient improves security operations by fusing disparate data sources, tools, and teams to accelerate threat detection, investigation, and response (TDIR). ThreatQ is the first purpose-built, data-driven threat intelligence platform that helps teams prioritize, automate, and collaborate on security incidents; enables more focused decision-making; and maximizes limited resources by integrating existing processes and technologies into a unified workspace. The result is reduced noise, clear priority threats, and the ability to automate processes with high-fidelity data. ThreatQuotient's leading integration marketplace, data management, orchestration, and automation capabilities support multiple use cases including threat intelligence management and sharing, incident response, threat hunting, spear phishing, alert triage, and vulnerability management. For more information, visit
